Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

checkorphan
Learn more about:
Adenomyosis
Related Clinical Trial
Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

Official Title

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? A Randomized Controlled Trial Comparing 3D Laparoscopy Versus Standard Laparoscopy

Brief Summary

      The objective aim is to evaluate whether the use of 3D laparoscopy facilitates the vaginal
      cuff closure of the vaginal cuff during a total laparoscopic hysterectomy among novice
      laparoscopists (PGY 2-4, Fellow). This is a randomized single blinded controlled trial
      comparing the difference in 2D vs. 3D in regards to vaginal cuff closure time stratified by
      residents and fellows. Patients will undergo a total laparoscopic hysterectomy and will be
      randomized to either 2D versus 3D.

Detailed Description

      This is a randomized single blinded controlled trial investigating 3D laparoscopy in the
      clinical setting. Based on previous studies indicating 3D laparoscopy has improved skills of
      novice surgeons in the simulation lab, there has been no reports to date investigating the
      role of 3D laparoscopy in the operating room. Our study will evaluate the facility of 3D
      laparoscopy in the novice surgeon, mainly residents and fellow. Patients who present for a
      scheduled total laparoscopic hysterectomy will be randomized to either the standard 2D
      laparoscopy system or 3D laparoscopy system. Stratifying residents versus fellow, we will
      compare the time to close the vaginal cuff comparing both systems.

Study Type

Interventional

Primary Outcome

Vaginal Cuff Closure Times

Secondary Outcome

 Estimated Blood Loss at the Time of Total Laparoscopic Hysterectomy

Condition

Uterine Fibroids

Intervention

Storz 3D Laparoscopy System

Study Arms / Comparison Groups

 2D Laparoscopy
Description:  The standard 2D Laparoscopy System to be used at time of the total laparoscopic hysterectomy

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Device

Estimated Enrollment

57

Start Date

November 2013

Completion Date

September 2016

Primary Completion Date

August 2016

Eligibility Criteria

        Inclusion Criteria:

          -  Women with benign conditions such as uterine fibroids, menorrhagia, adenomyosis,
             pelvic pain, abnormal uterine bleeding

        Exclusion Criteria:

          -  None

Gender

Female

Ages

18 Years - 80 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Jon Einarsson, MD, PhD, MPH, ,

Location Countries

Denmark

Location Countries

Denmark

Administrative Informations

NCT ID

NCT02192606

Organization ID

3DRCT

Responsible Party

Principal Investigator

Study Sponsor

Brigham and Women's Hospital

Study Sponsor

Jon Einarsson, MD, PhD, MPH, Principal Investigator, Brigham and Women's Hospital

Verification Date

January 2018